Drug recall · November 4, 2020
Hydrocortisone butyrate Cream recall
Why: SUBPOTENT DRUG
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Hydrocortisone butyrate Cream, 0.1%, 15-gram tubes, Rx Only, Manufactured for Oceanside Pharmaceuticals a division of Valeant Pharmaceuticals North America LLC Bridgewater, NJ 08807 USA, By: Ferndale Laboratories, Inc. Ferndale, MI 48220, NDC 68682-270-15
- Lots / codes
Lot #: 18125C, Exp. Date 09/2020; 19079B, Exp. Date 5/2021; 19142B, Exp. Date 09/2021; 19167B, Exp. Date 10/2021
- Quantity
- 35424 units
- Company
- Bausch Health Companies, Inc., Bridgewater, NJ
- Distribution
- Nationwide within the United States
- Initiated
- July 13, 2020 · Voluntary: Firm initiated
- Classified
- October 26, 2020
- Reported
- November 4, 2020
- Ended
- March 3, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrocortisone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.